Searched for
DIABETES DRUGS
GLP-1 drugs create new market for collagen, protein and beauty products in IndiaThe rising use of GLP-1 weight-loss drugs such as Ozempic and Mounjaro is creating a new consumer market in India, with companies developin...- Delhi High Court rules in favour of Dr Reddy's Labs in trademark row with RazentaThe Delhi High Court ordered the removal of Razenta Pharmaceuticals' Daplogin trademark. This decision came as the mark was deemed deceptiv...
- Acquired new tastes & distastes: India’s health warnings are loud. Its consumption habits are louderDespite health warnings, cigarette production surged 24%, while wine consumption rose 25% among the young. Conversely, production of fruit ...
- In 2019, research began with users of anti-diabetes treatment medicines, now study shows side effect could be hair lossDiabetes treatment: The researchers said while the study was a rigorous one, based on high quality data from a large representative cohort,...
- Widening waistline: India's big, fat obesity hotspots may not be just the biggest cities anymoreIndia sees a significant rise in overweight and obese populations recently. Rural areas show a particularly sharp increase in these health ...
- International Youth Day 2026: Why Indians in their 20s are facing diabetes, BP, fatty liverIn celebration of International Youth Day, we acknowledge the significant role played by young individuals in society, alongside their heal...
- Sun will require HC nod for Semaglutide tablet launchThe Delhi High Court has directed Sun Pharma Laboratories to seek its approval before launching semaglutide tablets, following Novo Nordisk...
- Parliamentary panel recommends mandatory kidney tests for all aged 20 yrs and above every 6 monthsA parliamentary committee proposes mandatory kidney function tests for adults aged twenty and above. High-risk individuals will undergo ann...
- UK first in Europe to approve Eli Lilly oral weight loss drugBritain has become the first country in Europe to approve orforglipron, the oral weight loss and diabetes treatment developed by US company...
- Eli Lilly’s Foundayo becomes first oral weight-loss drug approved in UK for diabetesBritain's regulator approved Eli Lilly's Foundayo pill for weight and diabetes. This treatment is not yet available through the NHS in the ...
- Picking the right pharma stock is getting harder; so pick a portfolio: 20 stocks with -23% to +22% downside to upside potentialFor Indian pharma, the regulatory risk is still real. A US FDA inspection can still cause trouble. A plant making an important product or g...
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsA word of caution for all those who have exposure to mid cap stocks or are planning to increase it. Just keep one thing in mind: If there i...
- Novo CEO says setbacks demand faster research, acquisitions as investors fret over pipelineNovo Nordisk CEO Mike Doustdar said the company will speed up research and pursue smaller acquisitions to strengthen its drug pipeline afte...
- Drugmaker Pfizer beats earnings estimates, targets $2.5 billion in additional cost cutsPfizer has reported impressive second-quarter earnings, driven by the success of Eliquis and newly acquired pharmaceutical products. The co...
- Government tightens surveillance on GLP-1 weight-loss drug promotion amidst surrogate advertising concernsCentral government directs state regulators to enhance surveillance over GLP-1 drug promotion. Approved GLP-1 drugs are only for Type 2 dia...
- Type 2 diabetes patients on metformin, take note: After 60 years, scientists find this drug has hidden effects on the brainDiabetes: Recent studies reveal that metformin may influence blood sugar management via the brain. This medication stimulates a distinct br...
- Type 2 diabetes medicine widely used since 1922 may affect blood sugar patient's brain, claims recent studyMetformin may have been part of diabetes medicine for generations, but scientists are still uncovering new chapters in its story. The possi...
- For GLP-1 users, the in-store clothes shopping trip is backMany consumers using weight-loss drugs are now shopping more in physical stores. Sizing changes prompt shoppers to try on clothes, increasi...
- Losing weight fast on GLP-1 drugs? Your hair could be the next thing to goDermatologists report increased hair loss among GLP-1 drug users experiencing rapid weight reduction. This side effect, often telogen efflu...
- Novo Nordisk pursues preliminary injunction to block Eli Lilly weight-loss drug adsNovo Nordisk is seeking a court injunction to stop Eli Lilly's drug advertisements. The Danish company claims Lilly's ads mislead consumers...
Load More
